These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16616187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
    Horta BA, Sodero AC, de Alencastro RB.
    J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
    [Abstract] [Full Text] [Related]

  • 3. The comparison of VEGFR-1-binding domain of VEGF-A with modelled VEGF-C sheds light on receptor specificity.
    Kasap M, Sazci A.
    J Theor Biol; 2008 Aug 07; 253(3):446-51. PubMed ID: 18479712
    [Abstract] [Full Text] [Related]

  • 4. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A, Leppänen VM, Tvorogov D, Zarkada G, Jeltsch M, Holopainen T, Kaijalainen S, Alitalo K.
    Sci Signal; 2013 Jul 02; 6(282):ra52. PubMed ID: 23821770
    [Abstract] [Full Text] [Related]

  • 5. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ.
    J Mol Biol; 2002 Feb 22; 316(3):769-87. PubMed ID: 11866530
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment.
    Leonard P, Scotney PD, Jabeen T, Iyer S, Fabri LJ, Nash AD, Acharya KR.
    J Mol Biol; 2008 Dec 31; 384(5):1203-17. PubMed ID: 18930733
    [Abstract] [Full Text] [Related]

  • 7. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
    Starovasnik MA, Christinger HW, Wiesmann C, Champe MA, de Vos AM, Skelton NJ.
    J Mol Biol; 1999 Oct 29; 293(3):531-44. PubMed ID: 10543948
    [Abstract] [Full Text] [Related]

  • 8. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
    Zheng Y, Murakami M, Takahashi H, Yamauchi M, Kiba A, Yamaguchi S, Yabana N, Alitalo K, Shibuya M.
    Arterioscler Thromb Vasc Biol; 2006 Sep 29; 26(9):2019-26. PubMed ID: 16794222
    [Abstract] [Full Text] [Related]

  • 9. The C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1.
    Inder MK, Wise LM, Fleming SB, Mercer AA.
    FEBS J; 2008 Jan 29; 275(1):207-17. PubMed ID: 18076652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
    Chen WS, Kitson RP, Goldfarb RH.
    In Vivo; 2002 Jan 29; 16(6):439-45. PubMed ID: 12494887
    [Abstract] [Full Text] [Related]

  • 12. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
    Fujisawa D, Yamazaki Y, Lomonte B, Morita T.
    Biochem J; 2008 May 01; 411(3):515-22. PubMed ID: 18251716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor.
    Ueda N, Inder MK, Wise LM, Fleming SB, Mercer AA.
    Virus Res; 2007 Mar 01; 124(1-2):50-8. PubMed ID: 17109982
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.